Obesity, insulin resistance, and type 1 diabetes mellitus

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 22, Issue 4, 2015, Pages 277-282

  Polsky, Sarit ^a   Ellis, Samuel L ^b  

^a UNIVERSITY OF COLORADO DENVER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

complications; diabetes mellitus; insulin resistance; obesity; overweight

Indexed keywords

BIGUANIDE DERIVATIVE; EXENDIN 4; GLUCAGON; METFORMIN; SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR;

AUTOIMMUNITY; BARIATRIC SURGERY; COMORBIDITY; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE PREDISPOSITION; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MICROANGIOPATHY; OBESITY; REVIEW; DIABETES MELLITUS, TYPE 1; METABOLISM; PHYSIOLOGY;

COMORBIDITY; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN RESISTANCE; OBESITY;

EID: 84937773827     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000170     Document Type: Review

References (29)

1. Minges KE, Whittemore R, Grey M. Overweight and obesity in youth with type 1 diabetes. Annu Rev Nurs Res. 2013; 31: 47-69
2. Exchange TD. Risks of obesity in youth with T1D; 2014 [updated 21 July. 2014; cited 3 March 2015]. https: //t1dexchange.org/pages/risks-of-obesityin-youth-with-T1d/.[Accessed 3 March 2015
3. Liu LL, Lawrence JM, Davis C, et al. Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes. 2010; 11: 4-11
4. Islam ST, Abraham A, Donaghue KC, et al. Plateau of adiposity in Australian children diagnosed with Type 1 diabetes: a 20-year study. Diabet Med. 2014; 31: 686-690
5. Pinhas-Hamiel O, Levek-Motola N, Kaidar K, et al. Prevalence of overweight, obesity and metabolic syndrome components in children, adolescents and young adults with type 1 diabetes mellitus. Diabetes Metab Res Rev. 2015; 31: 76-84
6. Baskaran C, Volkening LK, Diaz M, et al A decade of temporal trends in overweight/obesity in youth with type 1 diabetes after the Diabetes Control and Complications Trial. Pediatr Diabetes 2014
7. Frohlich-Reiterer EE, Rosenbauer J, Bechtold-Dalla Pozza S, et al. Predictors of increasing BMI during the course of diabetes in children and adolescents with type 1 diabetes: data from the German/Austrian DPV multicentre survey. Arch Dis Child. 2014; 99: 738-743
8. Fourlanos S, Elkassaby S, VarneyMD, et al. Higher body mass index in adults at diagnosis of the slowly progressive formof type 1 diabetes mellitus is associated with lower risk HLA genes. Diabetes Res Clin Pract. 2014; 104: e69-e71
9. Holt SK, Lopushnyan N, Hotaling J, et al. Prevalence of low testosterone and predisposing risk factors in men with type 1 diabetes mellitus: findings from the DCCT/EDIC. J Clin Endocrinol Metab. 2014; 99: E1655-E1660
10. Price SA, Gorelik A, Fourlanos S, et al. Obesity is associated with retinopathy and macrovascular disease in type 1 diabetes. Obes Res Clin Pract. 2014; 8: e178-e182
11. Vestberg D, Rosengren A, Olsson M, et al. Relationship between overweight and obesity with hospitalization for heart failure in 20 985 patients with type 1 diabetes: a population-based study from the Swedish National Diabetes Registry. Diabetes Care. 2013; 36: 2857-2861
12. Arafat AM, Weickert MO, Adamidou A, et al. The impact of insulin-independent, glucagon-induced suppression of total ghrelin on satiety in obesity and type 1 diabetes mellitus. J Clin Endocrinol Metab. 2013; 98: 4133-4142
13. Depoortere I. Targeting the ghrelin receptor to regulate food intake. Regul Pept. 2009; 156: 13-23
14. Wilkin TJ. The accelerator hypothesis: weight gain as the missing link between type i and type ii diabetes. Diabetologia. 2001; 44: 914-922
15. Islam ST, Srinivasan S, Craig ME. Environmental determinants of type 1 diabetes: a role for overweight and insulin resistance. J Paediatr Child Health. 2014; 50: 874-879
16. Dahlquist G. Can we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis. Diabetologia. 2006; 49: 20-24
17. Harpsoe MC, Basit S, Andersson M, et al. Body mass index and risk of autoimmune diseases: a study within the Danish National Birth Cohort. Int J Epidemiol. 2014; 43: 843-855
18. Versini M, Jeandel PY, Rosenthal E, et al. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev. 2014; 13: 981-1000
19. Cedillo M, Libman IM, Arena VC, et al. Obesity, islet cell autoimmunity, and cardiovascular risk factors in youth at onset of type 1 autoimmune diabetes. J Clin Endocrinol Metab. 2015; 100: E82-E86
20. Kastelan S, Salopek Rabatic J, Tomic M, et al. Body mass index and retinopathy in type 1 diabetic patients. Int J Endocrinol. 2014; 2014: 387919
21. Chillaron JJ, Flores Le-Roux JA, Benaiges D, et al. Type 1 diabetes, metabolic syndrome and cardiovascular risk. Metabolism. 2014; 63: 181-187
22. Burchardt P, Zawada A, Tabaczewski P, et al. Metformin added to intensive insulin therapy reduces plasma levels of glycated but not oxidized lowdensity lipoprotein in young patients with type 1 diabetes and obesity in comparison with insulin alone: a pilot study. Pol Arch Med Wewn 2013; 123:526-532
23. Vella S, Buetow L, Royle P, et al. The use of metformin in type 1 diabetes: a systematic review of efficacy. Diabetologia. 2010; 53: 809-820
24. Sarkar G, Alattar M, Brown RJ, et al. Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes. Diabetes Care. 2014; 37: 666-670
25. Perkins BA, Cherney DZ, Partridge H, et al. Sodium-glucose cotransporter 2 inhibition and glycemic control in type 1 diabetes: results of an 8-week openlabel proof-of-concept trial. Diabetes Care. 2014; 37: 1480-1483
26. Chuang J, Zeller MH, Inge T, et al. Bariatric surgery for severe obesity in two adolescents with type 1 diabetes. Pediatrics. 2013; 132: e1031-1034
27. Fuertes-Zamorano N, Sanchez-Pernaute A, Torres Garcia AJ, et al. Bariatric surgery in type 1 diabetes mellitus; long-Term experience in two cases. Nutr Hosp. 2013; 28: 1333-1336
28. Bailey CJ. Metformin: effects on micro and macrovascular complications in type 2 diabetes. Cardiovasc Drugs Ther. 2008; 22: 215-224
29. Konrad K, Datz N, Engelsberger I, et al. Current use of metformin in addition to insulin in pediatric patients with type 1 diabetes mellitus: an analysis based on a large diabetes registry in Germany and Austria. Pediatr Diabetes 2014